A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects

Clinical Therapeutics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles